US Stock MarketDetailed Quotes

BDTX Black Diamond Therapeutics

Watchlist
  • 1.570
  • -0.030-1.88%
Trading Apr 30 09:39 ET
88.98MMarket Cap-1.24P/E (TTM)

Black Diamond Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-8.88%78.78M
-12.37%18.28M
-24.50%18.13M
10.47%22.13M
-6.10%20.25M
-6.86%86.46M
-4.56%20.86M
8.53%24.01M
-13.55%20.03M
-16.04%21.56M
Selling and administrative expenses
1.32%27.47M
7.40%5.98M
-33.62%5.22M
39.20%9.57M
-1.57%6.7M
-4.51%27.11M
-23.15%5.57M
25.19%7.86M
-1.43%6.88M
-13.75%6.81M
-General and administrative expense
1.32%27.47M
7.40%5.98M
-33.62%5.22M
39.20%9.57M
-1.57%6.7M
-4.51%27.11M
-23.15%5.57M
25.19%7.86M
-1.43%6.88M
-13.75%6.81M
Research and development costs
-13.54%51.31M
-19.57%12.3M
-20.06%12.91M
-4.55%12.56M
-8.19%13.55M
-7.89%59.35M
4.65%15.29M
1.94%16.15M
-18.78%13.15M
-17.05%14.75M
Operating profit
8.88%-78.78M
12.37%-18.28M
24.50%-18.13M
-10.47%-22.13M
6.10%-20.25M
6.86%-86.46M
4.56%-20.86M
-8.53%-24.01M
13.55%-20.03M
16.04%-21.56M
Net non-operating interest income expense
13.41%2.18M
74.38%565K
17.54%516K
-13.91%464K
2.41%637K
-5.27%1.92M
-52.14%324K
-21.89%439K
39.64%539K
53.20%622K
Non-operating interest income
13.41%2.18M
74.38%565K
17.54%516K
-13.91%464K
2.41%637K
-5.27%1.92M
-52.14%324K
-21.89%439K
39.64%539K
53.20%622K
Other net income (expense)
230.61%6.92M
53.61%1.73M
263.43%2.06M
415.25%1.76M
2,062.50%1.38M
662.90%2.09M
1,057.73%1.12M
715.22%566K
338.46%341K
127.35%64K
Other non- operating income (expenses)
230.61%6.92M
53.61%1.73M
263.43%2.06M
415.25%1.76M
2,062.50%1.38M
691.53%2.09M
876.52%1.12M
715.22%566K
338.46%341K
127.35%64K
Income before tax
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
Income tax
Net income
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
Net income continuous Operations
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
Minority interest income
Net income attributable to the parent company
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
15.48%-69.68M
17.64%-15.99M
32.38%-15.56M
-3.95%-19.91M
12.69%-18.23M
9.57%-82.44M
7.92%-19.41M
-6.25%-23.01M
16.48%-19.15M
18.16%-20.88M
Basic earnings per share
32.45%-1.27
17.65%-0.28
37.78%-0.28
30.77%-0.36
38.60%-0.35
25.40%-1.88
42.37%-0.34
25.00%-0.45
17.46%-0.52
18.57%-0.57
Diluted earnings per share
32.45%-1.27
17.65%-0.28
37.78%-0.28
30.77%-0.36
38.60%-0.35
25.40%-1.88
42.37%-0.34
25.00%-0.45
17.46%-0.52
18.57%-0.57
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -8.88%78.78M-12.37%18.28M-24.50%18.13M10.47%22.13M-6.10%20.25M-6.86%86.46M-4.56%20.86M8.53%24.01M-13.55%20.03M-16.04%21.56M
Selling and administrative expenses 1.32%27.47M7.40%5.98M-33.62%5.22M39.20%9.57M-1.57%6.7M-4.51%27.11M-23.15%5.57M25.19%7.86M-1.43%6.88M-13.75%6.81M
-General and administrative expense 1.32%27.47M7.40%5.98M-33.62%5.22M39.20%9.57M-1.57%6.7M-4.51%27.11M-23.15%5.57M25.19%7.86M-1.43%6.88M-13.75%6.81M
Research and development costs -13.54%51.31M-19.57%12.3M-20.06%12.91M-4.55%12.56M-8.19%13.55M-7.89%59.35M4.65%15.29M1.94%16.15M-18.78%13.15M-17.05%14.75M
Operating profit 8.88%-78.78M12.37%-18.28M24.50%-18.13M-10.47%-22.13M6.10%-20.25M6.86%-86.46M4.56%-20.86M-8.53%-24.01M13.55%-20.03M16.04%-21.56M
Net non-operating interest income expense 13.41%2.18M74.38%565K17.54%516K-13.91%464K2.41%637K-5.27%1.92M-52.14%324K-21.89%439K39.64%539K53.20%622K
Non-operating interest income 13.41%2.18M74.38%565K17.54%516K-13.91%464K2.41%637K-5.27%1.92M-52.14%324K-21.89%439K39.64%539K53.20%622K
Other net income (expense) 230.61%6.92M53.61%1.73M263.43%2.06M415.25%1.76M2,062.50%1.38M662.90%2.09M1,057.73%1.12M715.22%566K338.46%341K127.35%64K
Other non- operating income (expenses) 230.61%6.92M53.61%1.73M263.43%2.06M415.25%1.76M2,062.50%1.38M691.53%2.09M876.52%1.12M715.22%566K338.46%341K127.35%64K
Income before tax 15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M-6.25%-23.01M16.48%-19.15M18.16%-20.88M
Income tax
Net income 15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M-6.25%-23.01M16.48%-19.15M18.16%-20.88M
Net income continuous Operations 15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M-6.25%-23.01M16.48%-19.15M18.16%-20.88M
Minority interest income
Net income attributable to the parent company 15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M-6.25%-23.01M16.48%-19.15M18.16%-20.88M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 15.48%-69.68M17.64%-15.99M32.38%-15.56M-3.95%-19.91M12.69%-18.23M9.57%-82.44M7.92%-19.41M-6.25%-23.01M16.48%-19.15M18.16%-20.88M
Basic earnings per share 32.45%-1.2717.65%-0.2837.78%-0.2830.77%-0.3638.60%-0.3525.40%-1.8842.37%-0.3425.00%-0.4517.46%-0.5218.57%-0.57
Diluted earnings per share 32.45%-1.2717.65%-0.2837.78%-0.2830.77%-0.3638.60%-0.3525.40%-1.8842.37%-0.3425.00%-0.4517.46%-0.5218.57%-0.57
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Alibaba
BABA
118.913
Netflix
NFLX
1115.680
Qualcomm
QCOM
145.140
4
Cisco
CSCO
56.618
5
Adobe
ADBE
365.882
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.